Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

The Cannabist Company Holdings Inc.

Healthcare US CBSTF

NoneUSD
0.00(0%)

Last update at 2026-06-23T21:01:33.516608Z

Day Range

--
LowHigh

52 Week Range

0.020.16
LowHigh

Fundamentals

  • Previous Close 0.03
  • Market Cap14.48M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-13.07900M
  • Revenue TTM349.84M
  • Revenue Per Share TTM0.72
  • Gross Profit TTM 103.25M
  • Diluted EPS TTM-0.38

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -61.81900M -168.89800M -432.69400M -146.71400M -136.86500M
Minority interest -0.76000M -1.42500M 5.48M 3.76M 22.42M
Net income -105.88600M -175.71200M -416.00500M -143.09700M -110.77600M
Selling general administrative 159.51M 158.85M 617.45M 195.73M 124.42M
Selling and marketing expenses 3.94M 5.89M - - -
Gross profit 168.30M 179.97M 201.21M 194.01M 65.98M
Reconciled depreciation 48.98M 62.73M 84.79M 53.00M 30.27M
Ebit -20.37100M -114.97385M - -28.36000M -
Ebitda 28.61M -52.24485M - - -
Depreciation and amortization 48.98M 62.73M - - -
Non operating income net other - - - - -
Operating income -22.27200M -105.24000M -416.24000M -38.03700M -74.09700M
Other operating expenses 480.99M 616.57M - - -
Interest expense 41.45M 54.87M 53.90M 30.01M -
Tax provision 43.31M 5.39M -11.21300M 0.14M -3.66500M
Interest income - - - - -
Net interest income -37.97800M -50.68700M -53.89700M -30.01400M -13.83100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 43.31M 5.39M -11.21300M 0.14M -16.19700M
Total revenue 458.72M 511.33M 511.58M 460.08M 179.50M
Total operating expenses 190.57M 285.21M 927.82M 498.12M 253.60M
Cost of revenue 290.43M 331.36M 310.37M 266.06M 113.53M
Total other income expense net -39.54700M -63.65800M -16.45400M -78.66300M -48.93700M
Discontinued operations - - - - -
Net income from continuing ops -105.12600M -174.28700M -421.48100M -146.85300M -133.20000M
Net income applicable to common shares - - - -143.09700M -95.78700M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 696.17M 823.11M 994.73M 1376.51M 792.59M
Intangible assets 51.25M 76.77M 145.26M 367.79M 100.34M
Earning assets - - - - -
Other current assets 29.34M 12.02M 0.69M 7.94M 7.88M
Total liab 726.23M 757.76M 787.82M 825.69M 470.71M
Total stockholder equity -30.05900M 66.87M 206.90M 571.39M 341.59M
Deferred long term liab - - - - -
Other current liab 30.58M 8.28M 31.81M 64.47M 75.13M
Common stock - - - - -
Capital stock 0.00000M 0.00000M 0.00000M 0.00000M 533.74M
Retained earnings -1185.50100M -1079.28200M -904.00300M -468.33500M -325.23800M
Other liab - - - 176.40M 14.87M
Good will 0.00000M 0.00000M 19.27M 184.02M 132.81M
Other assets - - - 12.26M 42.18M
Cash 33.61M 35.76M 48.15M 82.20M 61.11M
Cash and equivalents - - - - -
Total current liabilities 228.71M 160.04M 203.12M 244.00M 148.88M
Current deferred revenue - - - - -
Net debt 444.81M 267.62M 280.87M 78.70M 23.42M
Short term debt 64.76M - - - -
Short long term debt 52.46M 5.91M 47.31M 1.88M 8.44M
Short long term debt total 478.42M - - - -
Other stockholder equity 1156.81M - - - -
Property plant equipment 378.65M - 577.89M 585.23M 307.56M
Total current assets 195.00M 187.53M 237.18M 226.44M 138.24M
Long term investments 12.65M 0.78M 0.78M 0.78M -
Net tangible assets - - - 19.59M 68.72M
Short term investments - - - - -
Net receivables 37.53M 15.60M 10.09M 19.41M 7.65M
Long term debt 249.51M 297.48M 281.70M 159.02M 76.09M
Inventory 94.52M 111.63M 127.91M 94.57M 54.80M
Accounts payable 41.12M 29.80M 23.77M 44.01M 18.47M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 26.84M 3.57M 399.56M 66.78M 18.52M
Deferred long term asset charges - - - - -
Non current assets total 501.18M 635.58M 757.55M 1150.07M 578.89M
Capital lease obligations 176.45M 242.94M 238.21M 260.42M 210.68M
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 30.98M -3.49900M -75.32700M -191.35000M -26.69700M
Change to liabilities - - 0.00000M 7.95M 5.38M
Total cashflows from investing activities - - - -191.35000M -27.32200M
Net borrowings -6.61000M -31.23700M - 71.91M 88.64M
Total cash from financing activities -9.00300M -14.12400M 153.68M 202.44M 89.99M
Change to operating activities - - - 94.19M 14.09M
Net income -105.12600M -174.28700M -416.00500M -143.09700M -95.78700M
Change in cash -1.40700M -10.15200M -33.04400M 10.56M 13.02M
Begin period cash flow 39.34M 49.49M 82.53M 71.97M 47.46M
End period cash flow 37.93M 39.34M 49.49M 82.53M 61.11M
Total cash from operating activities -23.37900M 7.47M -111.40100M -0.52300M -49.65000M
Issuance of capital stock 0.00000M 25.00M 0.00000M 133.56M -
Depreciation 48.98M 62.73M 84.79M 53.00M 19.65M
Other cashflows from investing activities -0.04900M 6.47M - -22.81100M 0.99M
Dividends paid - - - - -
Change to inventory -14.40800M 6.82M -44.30100M -18.03300M -17.25800M
Change to account receivables -5.59600M -2.81978M 8.09M -6.33300M -4.57400M
Sale purchase of stock - -0.47000M - 0.00000M 0.00000M
Other cashflows from financing activities -2.39300M -8.57722M - -1.22900M 0.96M
Change to netincome - - - 1.73M 24.23M
Capital expenditures 5.83M 9.97M 72.74M 117.51M 42.88M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 31.91M 24.99M -50.54500M 81.42M -0.49000M
Stock based compensation -1.00900M 5.46M 27.93M 25.02M 28.94M
Other non cash items 10.98M 114.57M -27.67800M -50.40000M 23.74M
Free cash flow -29.21000M -2.49500M -184.14200M -118.02900M -85.49100M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CBSTF
The Cannabist Company Holdings Inc.		 - -% - - 526.32 0.04 4.56 1.26 27.38
ZTS
Zoetis Inc		 0.95 1.25% 76.84 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.42 1.37% 30.98 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 6.43 4.31% 155.71 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 0.48 1.12% 43.42 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brands. In addition, the company provides management services to licensed entities. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The Cannabist Company Holdings Inc. was founded in 2012 and is headquartered in Chelmsford, Massachusetts.

The Cannabist Company Holdings Inc.

321 Billerica Rd., Chelmsford, MA, United States, 01824

Key Executives

Name Title Year Born
Mr. Michael James Abbott Co-Founder & Chairman 1965
Mr. David J. Hart CEO & Director 1977
Mr. Jesse Channon President 1985
Mr. Derek Watson Chief Financial Officer 1971
Mr. Bryan Lamont Olson Chief People & Administrative Officer 1974
Ms. Lee Ann Evans Vice President of Investor Relations NA
Kate Driscoll Vice President of Compliance NA
Mr. David Sirolly Chief Legal Officer & General Counsel 1975
Mr. Guy Jacques Hussussian Chief Data Officer 1967
Mr. Derek Watson Chief Financial Officer 1972

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.